Risk of nosocomial respiratory syncytial virus versus influenza among adult patients in acute care hospitals

被引:0
作者
Auvinen, Raija [1 ,2 ,3 ]
Huotari, Kaisa [1 ,2 ]
Nohynek, Hanna [3 ]
Syrjanen, Ritva K. [4 ]
Skogberg, Kirsi [1 ,2 ]
机构
[1] Helsinki Univ Hosp, Inflammat Ctr, Helsinki, Finland
[2] Univ Helsinki, Helsinki, Finland
[3] Finnish Inst Hlth & Welf, Dept Hlth Secur, Helsinki, Finland
[4] FVR Finnish Vaccine Res, Tampere, Finland
关键词
Respiratory syncytial virus; Influenza; Nosocomial; Adult; Incidence; ACQUIRED INFLUENZA; INFECTIONS; OUTBREAK; TRANSMISSION; DEFINITION; HEMATOLOGY;
D O I
10.1016/j.infpip.2024.100431
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: While nosocomial influenza is common, the risk of transmission in acute care remains unclear in the absence of systematic surveillance. Even less is known about the risk of nosocomial respiratory syncytial virus (RSV) among immunocompetent adults. Aim: To compare the proportions and incidences of nosocomial cases caused by these two similar respiratory infections among hospitalized adults. Methods: A retrospective study was conducted at two tertiary care hospitals in Southern Finland. Data on all hospitalized adult patients with a positive RSV or influenza test during 2016-22 were used to detect all nosocomial and community-acquired RSV and influenza cases. The proportion of nosocomial cases of all hospitalized cases was calculated. The incidences of nosocomial cases per 1000 bed-days were calculated by season and ward type for the five seasons before the COVID-19 pandemic. Results: Nosocomial RSV and influenza occurred in 2.8% and 8.1% of all hospitalized adult patients with a laboratory-confirmed infection. Over five seasons, 2016-20, the total incidences of nosocomial RSV and influenza cases per 1000 bed-days were 0.027 (95% confidence interval: 0.013, 0.050) and 0.32 (0.27, 0.39). Nosocomial RSV infections were especially poorly recorded with a virus-specific ICD-10 diagnosis code listed for only 16.7% of RSV and 59.8% of nosocomial influenza patients. Conclusion: Despite preventive measures, the incidence of nosocomial influenza was more than tenfold, and the proportion of nosocomial cases was almost threefold compared with RSV among hospitalized adults in acute care. Prevention and surveillance of both nosocomial influenza and RSV should be improved also among immunocompetent adult patients. (c) 2025 Published by Elsevier Ltd on behalf of The Healthcare Infection Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Evaluation of the ImmuView RSV Test for Rapid Detection of Respiratory Syncytial Virus in Adult Patients with Influenza-Like Symptoms
    Larsson, E.
    Johansson, S.
    Frobert, O.
    Nordenskjold, A.
    Athlin, S.
    MICROBIOLOGY SPECTRUM, 2021, 9 (03):
  • [32] Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study
    Hartnett, Jessica
    Donga, Prina
    Ispas, Gabriela
    Vandendijck, Yannick
    Anderson, David
    House, Stacey
    Suner, Selim
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (05) : 906 - 915
  • [33] Absence of nosocomial influenza and respiratory syncytial virus infection in the coronavirus disease 2019 (COVID-19) era: Implication of universal masking in hospitals
    Wong, Shuk-Ching
    Lam, Germaine Kit-Ming
    Auyeung, Christine Ho-Yan
    Chan, Veronica Wing-Man
    Wong, Newton Lau-Dan
    So, Simon Yung-Chun
    Chen, Jonathan Hon-Kwan
    Hung, Ivan Fan-Ngai
    Chan, Jasper Fuk-Woo
    Yuen, Kwok-Yung
    Cheng, Vincent Chi-Chung
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (02) : 218 - 221
  • [34] Distribution of Airborne Influenza Virus and Respiratory Syncytial Virus in an Urgent Care Medical Clinic
    Lindsley, William G.
    Blachere, Francoise M.
    Davis, Kristina A.
    Pearce, Terri A.
    Fisher, Melanie A.
    Khakoo, Rashida
    Davis, Stephen M.
    Rogers, Mark E.
    Thewlis, Robert E.
    Posada, Jose A.
    Redrow, John B.
    Celik, Ismail B.
    Chen, Bean T.
    Beezhold, Donald H.
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (05) : 693 - 698
  • [35] Multicenter evaluation of molecular point-of-care testing and digital immunoassays for influenza virus A/B and respiratory syncytial virus in patients with influenza-like illness
    Kaku, Norihito
    Kodama, Hina
    Akamatsu, Norihiko
    Ota, Kenji
    Kosai, Kosuke
    Morinaga, Yoshitomo
    Narita, Yusuke
    Matsumoto, Yasushi
    Matsushita, Tetsuro
    Mizuta, Yohei
    Izumikawa, Koichi
    Mukae, Hiroshi
    Yanagihara, Katsunori
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (06) : 820 - 825
  • [36] Contribution of respiratory syncytial virus, influenza and parainfluenza viruses to acute respiratory infections in San Luis Potosi, Mexico
    Noyola, DE
    Arteaga-Domínguez, G
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (12) : 1049 - 1052
  • [37] The Impact of Social Distancing for Severe Acute Respiratory Syndrome Coronavirus 2 on Respiratory Syncytial Virus and Influenza Burden
    Edwards, Kathryn M.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : 2076 - 2078
  • [38] Sensitivity and specificity of surveillance case definitions in detection of influenza and respiratory syncytial virus among hospitalized patients, New Zealand, 2012-2016
    Davis, William
    Duque, Jazmin
    Huang, Q. Sue
    Olson, Natalie
    Grant, Cameron C.
    Newbern, E. Claire
    Thompson, Mark
    Waite, Ben
    Prasad, Namrata
    Trenholme, Adrian
    Azziz-Baumgartner, Eduardo
    JOURNAL OF INFECTION, 2022, 84 (02) : 216 - 226
  • [39] Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncology
    Baier, Claas
    Linderkamp, Christin
    Beilken, Andreas
    Thol, Felicitas
    Heuser, Michael
    Ebadi, Ella
    Ganzenmueller, Tina
    Heim, Albert
    Bange, Franz-Christoph
    GMS HYGIENE AND INFECTION CONTROL, 2018, 13
  • [40] Prophylaxis and Treatment of Respiratory Syncytial Virus in Adult Immunocompromised Patients
    Hynicka, Lauren M.
    Ensor, Christopher R.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (04) : 558 - 566